Mutational and expression analysis of tbnat and its response to isoniazid

Journal of Medical Microbiology

Volumn 54, Issue 12, 2005, Pages 1189-1197

  Sholto Douglas Vernon, Carolyn ^a   Sandy, James ^b   Victor, Thomas C ^a   Sim, Edith ^b   Van Helden, Paul D ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; HISTIDINE; ISONIAZID; TYROSINE;

ACETYLATION; ARTICLE; BACTERIAL GROWTH; DRUG INACTIVATION; DRUG SENSITIVITY; ENZYME ACTIVE SITE; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; MYCOBACTERIUM TUBERCULOSIS; NAT GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA; STRAIN IDENTIFICATION; TBNAT GENE;

ANTITUBERCULAR AGENTS; ARYLAMINE N-ACETYLTRANSFERASE; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISONIAZID; MODELS, MOLECULAR; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN CONFORMATION; SOUTH AFRICA;

EID: 28944445819     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46153-0     Document Type: Article

References (42)

1. Alland, D., Kramnik, I., Weisbrod, T. R., Otsubo, L., Cerny, R., Miller, L. P., Jacobs, R. F., Jr & Bloom, B. R. (1908). Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of INH on gene expression in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 95, 13227-13232.
2. Anderton, M. C., Bhakta, S. Patrick, A. L. & Sim, E. (2004). Characterisation of the putative operon containing arylamine N-acetyltransferase (NAT) in mycobacteria. Drug Metab Rev 36, supplement 1, abstract 322.
3. Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Sun Um, K., Wilson, T., Collins, D., de Lisle, G. & Jacobs, W. R. (1994). inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263, 227-232.
4. Bhakta, S., Besra, G. S., Upton, A. & 8 other authors (2004). Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target. J Exp Med 199, 1191-1199.
5. Cangelosi, G. A. & Brabant, W. H. J. (1997). Depletion of pre-16S rRNA in starved Escherichia coli cells. Bacteriology 179, 4457-4463.
6. Carmo, M., Peiaxo, C., Coroadinha, A. S., Alves, P. M., Cruz, P. E. & Carrondo, M. J. T. (2004). Quantitation of MLV-based retroviral vectors using real-time RT-PCR. J Virol Methods 119, 115-119.
7. Cole, S. T, Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D. & Barrel, B. (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544.
8. Ellard, G. A. & Gammon, P. T. (1976). Pharmacokinetics of isoniazid metabolism in man. J Pharmacokinet Biopharm 4, 83-113.
9. Garbe, T. R., Hibler, N. S. & Deretic, V. (1996). Isoniazid induces expression of the antigen 85 complex in Mycobacterium tuberculosis. Antimicrob Agents Chemother 40, 1754-1756.
10. Gonzalez-y-Merchand, J. A., Colston, M. J. & Cox, R. A. (1998). Roles of multiple promoters in transcription of ribosomal DNA: effects of growth conditions on precursor rRNA synthesis in mycobacteria. J Bacteriol 180, 5756-5761.
11. Grange, J. M. & Zumla, A. (2002). The global emergency of tuberculosis: what is the cause? J R Soc Health 122, 78-81.
12. Gutacker, M. M., Smoot, J. C., Lux Migliaccio, C. A. & 7 other authors (2002). Genome-wide analysis of synonymous single nucleotide polymorphisms in Mycobacterium tuberculosis complex organisms: resolution of genetic relationships among closely related microbial strains. Genetics 162, 1533-1543.
13. Hansen, M. C., Nielsen, A. K., Molin, S., Hammer, K. & Kilstrup, M. (2001). Changes in rRNA levels during stress invalidates results from mRNA blotting: fluorescence in situ rRNA hybridization permits renormalization for estimation of cellular mRNA levels. J Bacteriol 183, 4747-4751.
14. Hellyer, T. J., DesJarden, L. E., Hehman, G. L., Cave, M. D. & Eisenach, K. D. (1999). Quantitative analysis of mRNA as a marker for viability of M. tuberculosis. J Clin Microbiol 37, 290-295.
15. Kawamura, A., Sandy, J., Upton, A., Noble, M. & Sim, E. (2003). Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase. Protein Expr Purif 27, 75-84.
16. Kelly, C. L., Rouse, D. A. & Morris, S. L. (1997). Analysis of aphC gene mutations in isoniazid resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 41, 2057-2058.
17. Lee, A. S., Teo, A. S. & Wong, S. Y. (2001). Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 45, 2157-2159.
18. Master, S., Zahrt, T. C., Song, J. & Deretic, V. (2001). Mapping of Mycobacterium tuberculosis katG promoters and their differential expression in infected macrophages. J Bacteriol 183, 4033-4039.
19. Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. & Barry, C. E. I. (1998). Inhibition of a Mycobacterium tuberculosis β-ketoacyl ACP synthase by isoniazid. Science 280, 1607-1610.
20. Meyers, P. R., Bourn, W. R., Steyn, L. M., van Helden, P. D., Beyers, A. D. & Brown, G. D. (1998). Novel method for rapid measurement of growth of mycobacteria in detergent-free media. J Clin Microbiol 36, 2752-2754.
21. Musser, M., Kapur, V., Williams, D., Kreiswirth, B., van Soolingen, D. & Van Embden, J. (1996). Characterisation of the catalase-peroxidase gene (katG) and inhA locus in isoniazid resistant and susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis 173, 196-202.
22. NCBI (2004). nhoAN-hydroxyarylamine O-acetyltransferase [Mycobacterium tuberculosis CDC1551] http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db= gene&cmd=Retrieve&dopt=Graphics&list_uids=926546
23. Parkin, D. P., Vandenplas, S., Botha, F. J., Vandenplas, M. L., Seifart, H. I., van Helden, P. D., van der Walt, B. J., Donald, P. R. & van Jaarsveld, P. P. (1997). Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis. Am J Respir Crit Care Med 155, 1717-1722.
24. Payton, M., Auty, R., Delgoda, R., Everett, M. & Sim, E. (1999). Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance. J Bacteriol 181, 1343-1347.
25. Payton, M., Gifford, C., Schartau, P., Hagaemier, C., Mushtaq, A., Lucas, S., Pinter, K. & Sim, E, (2001a). Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis. Microbiology 147, 3295-3302.
26. Payton, M., Mushtaq, A., Yu, T. W., Wu, L.-J., Sinclair, J. & Sim, E. (2001 b). Eubacterial arylamine N-acetyltransferases - identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues. Microbiology 147, 1137-1147.
27. Ramaswamy, S. & Musser, J. (1998). Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis. Tuber Lung Dis 79, 3-29.
28. Ramaswamy, S., Reich, R., Dou, S.-H., Jasperse, L., Pan, X., Wanger, A., Quitugua, T. & Gravis, E. A. (2003). Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 47, 1241-1250.
29. Sandy, J., Mushtaq, A., Holton, S. J., Noble, M. & Sim, E (2005). The catalytic triad of residues of arylamine N-acetyltransferase are all essential for catalytic activity. Biochem J 390, 115-123.
30. Sim, E., Payton, M., Noble, M. & Minchin, R. (2000). An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes. Hum Mol Genet 9, 2435-2441.
31. Slayden, R. A. & Barry, C. E. (2000). The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect 2, 659-669.
32. Torres, M. J., Criado, A., Palomares, J. C. & Aznar, J. (2000). Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. J Clin Microbiol 38, 3194-3199.
33. Upton, A., Mushtaq, A., Victor, T., Sampson, S. L., Sandy, J., Smith, D.-M., van Helden, P. & Sim, E. (2001). Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism. Mol Microbiol 42, 309-317.
34. Vainrub, A. & Montgomery Petitt, B. (2003). Surface electrostatic effects in oligonucleotide microarrays: control and optimization of binding thermodynamics. Biopolymers 68, 265-270.
35. Vandecasteele, S. J., Peetermans, W. E., Merck, R. & van Eldere, J. (2001). Quantification of expression of Staphylococcus epidermidis housekeeping genes with Taqman quantitative PCR during in vitro growth and under different conditions. J Bacteriol 183, 7094-7101.
36. van Rie, A., Warren, R., Mshanga, I. & 9 other authors (2001). Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 39, 636-641.
37. Victor, T., Warren, R., Beyers, N. & van Helden, P. (1997). Transmission of multidrug-resistant strains of Mycobacterium tuberculosis in a high incidence community. Eur J Clin Microbial Infect Dis 16, 548-549.
38. Victor, T. C., van Helden, P. D. & Warren, R. (2002). Prediction of drug resistance in M. tuberculosis: molecular mechanism, tools, and applications. IUBMB Life 53, 231-237.
39. Warren, R., Sampson, S. L., Richardson, M., van der Spuy, G. D., Lombard, C. J., Victor, T. C. & van Helden, P. (2000). Mapping of IS6110 flanking regions in clinical isolates of Mycobacterium tuberculosis demonstrates genome plasticity. Mol Microbiol 37, 1405-1416.
40. Weber, W. W. & Hein, D. W. (1985). Arylamine N-acetyltransferases. Pharmacol Rev 37, 25-79.
41. Wilson, M., De Risi, J., Kristensen, H. H., Imboden, P., Rane, S. & Brown, P. O. (1999). Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci U S A 96, 12833-12838.
42. WHO (2004). Anti-Tuberculosis Drug Resistance in the World. Report number 3. http://www.who.int/tb/publications/dotsplus_surveillance/en/index.html